- Home
- INDO vs CRIS Comparison
INDO vs CRIS Comparison
Compare INDO & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDO
- CRIS
- Stock Information
- Founded
- INDO 2018
- CRIS 2000
- Country
- INDO Indonesia
- CRIS United States
- Employees
- INDO N/A
- CRIS N/A
- Industry
- INDO Oil & Gas Production
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INDO Energy
- CRIS Health Care
- Exchange
- INDO Nasdaq
- CRIS Nasdaq
- Market Cap
- INDO 40.1M
- CRIS 32.8M
- IPO Year
- INDO 2019
- CRIS 2000
- Fundamental
- Price
- INDO $3.10
- CRIS $3.29
- Analyst Decision
- INDO
- CRIS Strong Buy
- Analyst Count
- INDO 0
- CRIS 3
- Target Price
- INDO N/A
- CRIS $23.00
- AVG Volume (30 Days)
- INDO 805.1K
- CRIS 243.3K
- Earning Date
- INDO 10-25-2024
- CRIS 02-06-2025
- Dividend Yield
- INDO N/A
- CRIS N/A
- EPS Growth
- INDO N/A
- CRIS N/A
- EPS
- INDO N/A
- CRIS N/A
- Revenue
- INDO $3,127,587.00
- CRIS $10,259,000.00
- Revenue This Year
- INDO N/A
- CRIS N/A
- Revenue Next Year
- INDO N/A
- CRIS N/A
- P/E Ratio
- INDO N/A
- CRIS N/A
- Revenue Growth
- INDO N/A
- CRIS 0.44
- 52 Week Low
- INDO $2.03
- CRIS $2.86
- 52 Week High
- INDO $6.65
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- INDO 51.50
- CRIS 44.97
- Support Level
- INDO $2.92
- CRIS $3.10
- Resistance Level
- INDO $3.31
- CRIS $3.60
- Average True Range (ATR)
- INDO 0.30
- CRIS 0.37
- MACD
- INDO 0.02
- CRIS 0.00
- Stochastic Oscillator
- INDO 45.36
- CRIS 26.22
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.